मधुबनी, अप्रैल 6 -- झंझारपुर। बेलारही स्थित राजकीय उत्क्रमित मध्य विद्यालय के चार प्रतिभाशाली छात्रों ने राष्ट्रीय साधन सह योग्यता छात्रवृत्ति (एनएमएमएस) परीक्षा में उत्कृष्ट प्रदर्शन कर विद्यालय और क... Read More
India, April 6 -- This part really gets to be fun for many players. How would a TMNT game let you not only choose a turtle but actually make you feel like one? That is what Empire City is all about. W... Read More
अयोध्या, अप्रैल 6 -- अयोध्या। गर्मी में शहर और जनपद के ग्रामीण क्षेत्रों में विद्युत आपूर्ति व्यवस्थ बनाये रखने और खराबियों को दूर करने को लेकर विभागीय स्तर पर मंथन चल रहा है। सोमवार को अधीक्षण अभियंत... Read More
New Delhi, April 6 -- The disciplinary body for China 's Communist Party said Friday it has placed the former Xinjiang party chief under investigation over suspected violations of discipline and law. ... Read More
Singapore, April 6 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More
Singapore, April 6 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More
Singapore, April 6 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More
Singapore, April 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More
Singapore, April 6 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More
Singapore, April 6 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... Read More